TMC
ACER

Trellus Management Company’s Acer Therapeutics Inc ACER Stock Holding History

Trellus Management Company’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-192
Closed -$35K – 119
2013
Q3 		$35K Buy
+192
New +$25.7K 0.04% 97

Other funds holding ACER

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Trellus Management Company's ACER Position: Q4 2013 in Review

Trellus Management Company sold out of Acer Therapeutics Inc (ACER) in Q4 2013, closing a stake of 192 shares — an estimated $35K sold.

Trellus Management Company first reported a position in ACER in Q3 2013 and held it in 1 quarter. The position peaked at $35K in Q3 2013. 18 funds tracked by Wall St. Rank hold ACER as of Q4 2013.

  • Trellus Management Company reported no remaining Acer Therapeutics Inc position as of Q4 2013 after selling out during the quarter.
  • Trellus Management Company sold 192 Acer Therapeutics Inc shares in Q4 2013, an estimated $35K.
  • Trellus Management Company first reported a position in Acer Therapeutics Inc in Q3 2013 and held it in 1 quarter.
  • Trellus Management Company's Acer Therapeutics Inc position peaked at $35K in Q3 2013.
  • 18 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2013.

Based on Trellus Management Company's 13F filing for Q4 2013, filed 14 Feb 2014.